Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Suparma Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Suparma Tbk. diperdagangkan di Rp172 (kapitalisasi pasar 927,49 M, volume 24 jam 1,3 jt). Perbedaan utamanya: Suparma Tbk. jauh lebih besar — sekitar 5,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Suparma Tbk. lebih aktif diperdagangkan (1,3 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SPMA | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 927,49 M |
Volume | 324 rb | 1,3 jt |
Lot | 3,24 rb | 13,04 rb |
Perputaran | 77,68 jt | 222,79 jt |
Harga Rata-rata | 239,75 | 170,84 |
Nilai Transaksi | 77,68 jt | 222,79 jt |
Harga Ekuilibrium Indikatif | 240 | 172 |
Volume Ekuilibrium Indikatif | 1 | 102 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Selengkapnya di halaman SPMA →